Capricor Therapeutics (CAPR) Current Leases (2021 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Current Leases of $841135.0 for Q1 2026, little changed year-over-year from $842101.0 in Q1 2025, and up 315.63% quarter-over-quarter from $202376.0 in Q4 2025.
Powered by 
Analysis
Capricor Therapeutics (CAPR) Current Leases (2021 - 2026) Analysis & Trends
Capricor Therapeutics' Current Leases history runs 6 years deep, the most recent figure standing at $841135.0 for Q1 2026.
- In Q1 2026, Current Leases changed 0.11% year-over-year to $841135.0; the TTM figure through Mar 2026 stood at $841135.0 (changed 0.11% YoY), while the FY2025 annual figure was $202376.0, down 75.76% from the prior year.
- Current Leases for Q1 2026 stood at $841135.0, up from $202376.0 in the prior quarter.
- The five-year high for Current Leases was $849505.0 in Q2 2025, with the low at $120094.0 in Q3 2025.
- The 5-year median for Current Leases is $729567.0 (2023), against an average of $670896.8.
- The sharpest annual moves came in 2022 and 2025: Current Leases surged 63.31% in 2022, then tumbled 85.24% in 2025.
- Capricor Therapeutics' Current Leases stood at $682039.0 in 2022, then rose by 9.83% to $749112.0 in 2023, then increased by 11.44% to $834799.0 in 2024, then tumbled by 75.76% to $202376.0 in 2025, then surged by 315.63% to $841135.0 in 2026.
- Business Quant data shows CAPR's Current Leases at $841135.0 in Q1 2026, $202376.0 in Q4 2025, and $120094.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Capricor Therapeutics | 543.30 Mn | 543.30 Mn | - | 1.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Mn |
| Mar 31, 2026 | 841,135.00 |
| Dec 31, 2025 | 202,376.00 |
| Sep 30, 2025 | 120,094.00 |
| Jun 30, 2025 | 849,505.00 |
| Mar 31, 2025 | 842,101.00 |
| Dec 31, 2024 | 834,799.00 |
| Sep 30, 2024 | 813,634.00 |
| Jun 30, 2024 | 792,694.00 |
| Mar 31, 2024 | 771,506.00 |
| Dec 31, 2023 | 749,112.00 |
| Sep 30, 2023 | 729,567.00 |
| Jun 30, 2023 | 707,425.00 |
| Mar 31, 2023 | 693,652.00 |
| Dec 31, 2022 | 682,039.00 |
| Sep 30, 2022 | 697,561.00 |
| Jun 30, 2022 | 579,672.00 |
| Mar 31, 2022 | 498,374.00 |
| Dec 31, 2021 | 417,632.00 |